|Security||GTIM / Good Times Restaurants, Inc. (382140879)|
|President, CEO||HOBACK BOYD E|
|Industry||Restaurants, Dining, and Eating Places|
|Institutional Shares||3,471,105 - 27.84%|
|Common Shares Outstanding||12,468,326 shares (as of 2018-03-27)|
|Institutional Value||$ 10,039,000 USD|
Institutional Stock Ownership and Shareholders()
Good Times Restaurants, Inc. (NASDAQ:GTIM) has 19 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,471,105 shares.
Largest shareholders include
Delta Partners Llc, Manatuck Hill Partners, LLC, Granite Point Capital Management, L.P., Vanguard Group Inc, Renaissance Technologies LLC, BlackRock Inc., Geode Capital Management, Llc, Wall Street Associates, Deutsche Bank Ag\, and Macquarie Group Ltd.
Good Times Restaurants, Inc. (NASDAQ:GTIM) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
|DELTA PARTNERS LLC||2,271,226||1,392,109||-38.71||6,132||3,689||-39.84|
|CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM||15,000||15,000||0.00||40||46||15.00|
|Granite Point Capital Management, L.P.||273,050||273,050||0.00||724||833||15.06|
|DIMENSIONAL FUND ADVISORS LP||16,162||49|
|Virtu Financial LLC||17,277||0||-100.00||46||0||-100.00|
|BlackRock Fund Advisors||33,271||34,123||2.56||112||107||-4.46|
|ROYAL BANK OF CANADA||9||0||-100.00||0||0|
|ACADIAN ASSET MANAGEMENT LLC||1,092||0||-100.00||3||0||-100.00|
|Baystate Wealth Management LLC||300||0||-100.00||1||0||-100.00|
|GEODE CAPITAL MANAGEMENT, LLC||56,983||56,983||0.00||151||173||14.57|
|DEUTSCHE BANK AG\||43,342||45,755||5.57||114||139||21.93|
|UBS Group AG||903||1,420||57.25||2||4||100.00|
|TWO SIGMA SECURITIES, LLC||16,274||0||-100.00||43||0||-100.00|
|Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio||614,500||0||-100.00||0||-100.00|
|Manatuck Hill Partners, LLC||1,041,400||1,041,400||0.00||2,760||3,176||15.07|
|WALL STREET ASSOCIATES||51,900||51,900||0.00||175||163||-6.86|
|MACQUARIE GROUP LTD||37,861||36,461||-3.70||100||111||11.00|
|BlackRock Institutional Trust Company, N.A.||25,936||25,936||0.00||87||82||-5.75|
|VANGUARD GROUP INC||232,022||256,374||10.50||615||782||27.15|
|BlackRock Investment Management, LLC||1,900||1,900||0.00||6||6||0.00|
|Renaissance Technologies LLC||74,700||106,000||41.90||198||323||63.13|
|BUCKHEAD CAPITAL MANAGEMENT LLC||17,600||12,700||-27.84||47||39||-17.02|
|NORTHERN TRUST CORP||22,757||22,757||0.00||60||69||15.00|
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
Related News Stories
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 22nd: (52-0)
GTIM operates Good Times Burgers and Frozen Custard as well as Bad Daddy's. Bad Daddy's, in particular, has some excellent reviews, and stores look like they're busy. That's good. (1-0)
Good Times Restaurants Inc. (NASDAQ:GTIM) Q1 2018 Earnings Conference Call May 10, 2018 5:00 PM ET (1-0)
The restaurant industry has been troubled by soft consumer spending environment over the past few quarters. Although the current economic backdrop is favorable with rise in in wages, jobless claims at a record low and upbeat consumer confidence, the benefits have not trickled down to the restaurant space yet. (75-0)
as of ET